You signed in with another tab or window. Reload to refresh your session.You signed out in another tab or window. Reload to refresh your session.You switched accounts on another tab or window. Reload to refresh your session.Dismiss alert
OWL is a biotechnology company that uses metabolomics to develop early diagnosis products for highly prevalent diseases. The first disease targeted was fatty liver disease (non-alcoholic fatty liver disease and non-alcoholic fatty liver disease)